Clinical Trial Update: 11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia Syndromes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining 11C-PIB PET/CT imaging in patients with Parkinson disease and Parkinsonian dementia syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinsonian Dementia

Drugs mentioned

• [11C]PIB (Pittsburgh compound-B)

Snippet

Sponsor: Oriental Neurosurgery Evidence-Based-Study Team | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN